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Abstract
Background: Antimicrobial helper-compounds may reverse antimicrobial resistance. Sertraline, a antidepressant
drug, has been suggested as a tetracycline helper-compound. Tetracycline is the preferred antimicrobial for
treatment of enteric diseases in pigs. This study is the first to evaluate the potency of sertraline as a tetracycline
adjuvant in pigs.
Methods: Forty-eight nursery pigs were divided into four treatment groups: Tetracycline, sertraline, tetracycline/sertraline
or un-medicated control. Fecal and ileal samples were obtained before treatment, 48 h and nine days after five days of
treatment, respectively. Colony forming units (CFU) of tetracycline resistant coliforms in each sample (ileal or fecal) and
CFU of an orally inoculated tetracycline-resistant strain of Escherichia coli were determined at each sampling point. The
microbiome of fecal and ileal and samples was analyzed by sequencing of the 16S V3-V4 region.
Results: The results did not provide evidence that sertraline in combination with tetracycline has any impact on
tetracycline resistant bacteria in either fecal or ileum samples, while in the tetracycline treated group of pigs, an increase
in the prevalence of a tetracycline resistant indicator strain of Escherichia coli shortly after ended five-day treatment was
observed. The ileal samples obtained shortly after ended treatment showed treatment-associated changes in the
composition of the microbiota in the groups of pigs treated with tetracycline (+/−) sertraline. While tetracycline treatment
increased the abundance in the reads of E. coli, sertraline/tetracycline treatment led to increased abundances of
Streptococcus spp. and decreased abundances of Lactobacillus spp. However, all observed differences (on CFU counts and
microbiota composition) between groups shortly after treatment had diminished in less than two weeks after last
treatment day.
Conclusions: Sertraline (+/−) tetracycline treatment did not reduce the long-term level of tetracycline-resistant bacteria
in the feces or small intestine contents of piglets compared to the un-medicated control group of pigs. The result of
this study reflects the importance of in vivo studies for confirmation of the antimicrobial helper-compound potential of
an in vitro active compound.
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Background
For many years tetracyclines have been the most commonly
used antimicrobials to treat pigs with enteric disease [1]. The
widespread uses of tetracyclines have been suggested as the
major cause of the increase in tetracycline resistant bacteria,
in particular in pigs [2]. Tetracyclines have been favored in
agriculture because of its broad-spectrum activity, low tox-
icity, many formulations for oral use and the relative low
price [3, 4], but the need to bring down the amount of anti-
microbials used in the livestock industry is inquisitional to in-
hibit further emergence of antimicrobial resistance [5, 6]. In
addition, antimicrobial helper-compounds have received
increased focus. Helper-compounds may be described as
drugs that enhance the activity of antibiotics [7]. Some
helper-compounds possess antimicrobial activities them-
selves [7], while others interfere with the resistance mechan-
ism of the bacterial resistance, e.g. by blocking antimicrobial
efflux pumps [8]. Sertraline, a selective serotonin reuptake in-
hibitor (SSRI), is a medical compound normally prescribed
for human mental disorders, such as depression and anxiety,
and it has been suggested as tetracycline helper-compound
by several research groups [9–13]. Although sertraline itself
do possess antimicrobial activity against a number of
Gram-negative bacterial species, the main reason of interest
for sertraline as a helper-compound is due to the interference
with the tetracycline resistant efflux pump, TetA [10, 13].
While several in vitro results have been published on the
antimicrobial helper-drug activities of SSRIs, including sertra-
line, only very limited literature on the clinical in vivo effect
of sertraline’s helper-compound activity exist.
The aim of the present study was to evaluate the influ-
ence of sertraline on the CFU of intestinal commensal
tetracycline coliforms in concurrent tetracycline treated
piglets compared to the level in non-medicated, sertra-
line - or only tetracycline treated groups of pigs. For the
same groups, the impact of treatment on the ileal micro-
biota composition was assessed.
Results
Level of tetracycline resistant bacteria in feces before
inoculation
Two days before treatment start and just prior to inocu-
lation of all pigs in all four groups (Time point T[− 2]
the level of fecal tetracycline resistant coliforms in the
48 individual fecal samples ranged from 3.3–7.7 log10
CFU per gram of feces (Fig. 1). None of the fecal sam-
ples contained bacteria which could be cultured on the
indicator agar plate (MacConkey agar supplemented
with tetracycline, ampicillin and rifampicin).
Level of tetracycline resistant bacteria in feces and ileum
immediately before treatment start
Two days after inoculation with the indicator bacteria
(Time point (T[0]), fecal samples were obtained from all
48 pigs, while ileal samples were obtained from two pigs
per treatment group. At T[0] the indicator bacteria
could be re-isolated (confirmed by PCR) in all fecal sam-
ples, while for one out of eight pigs the indicator bac-
teria could not be detected in the ileal samples at this
time point. The level of the indicator E. coli at T[0] in
fecal and ileum samples varied between 4.3–6.3 log10 to
0–4.1 log10 CFU/g, respectively, (Fig. 2). There was no
significant difference between the groups in the level of
the indicator E. coli at T[0] (Fig. 2,). Overall, in paired
fecal and ileum samples from the same pig there were
lower CFU counts observed in the ileum samples.
Level of tetracycline resistant bacteria in fecal/ileal
samples after treatment
Forty-eight hours after the last of five treatment days,
fecal samples were obtained from all pigs in each group
(Time point T[7]). Hereafter, five pigs from each group
were randomly chosen for euthanization and from these
pigs ileum samples were obtained as well. Nine days
later, fecal and ileum samples were obtained from the
remaining pigs in each group (Time point T[15]).
At T[7] there was significantly higher count of tetra-
cycline resistant coliform CFU per gram in fecal samples
obtained from tetracycline, sertraline or sertraline/tetra-
cycline treated pigs compared to the CFU per gram fecal
samples obtained from un-mediated control pigs (Fig. 1).
Similarly, ileum samples from un-mediated control pigs
contained significantly lower tetracycline resistant coli-
form CFU per gram compared to the tetracycline or ser-
traline treated group at T[7] (Fig. 1).Ileum samples from
the tetracycline treated group (Group 2) had a signifi-
cant higher level of the indicator E. coli compared to the
level in any of the other three groups (Fig. 3), while there
were no difference between the groups in the level of
the indicator bacteria in fecal samples (Fig. 2).
At T[15] there was no statistical significant difference
in any CFU counts between the four groups, whereas
there were several difference in CFU counts within each
of the groups (Fig. 1). There was a significant decrease
in total fecal tetracycline resistant coliform CFU per gram at
time T[15] compared with T[7] for the tetracycline treated
group (Group 2), the sertraline treated group (Group3) and
sertraline/tetracycline treated group (Group 4), respectively
(Fig. 1), while the were no difference in the level of fecal
tetracycline resistant coliform CFU in the control group.
The level of the indicator E. coli in feces also decreased sig-
nificantly from time T[0] to time T[15] in the tetracycline
and sertraline/tetracycline treated groups (Fig. 2).
Microbiota sequencing results
Sample preparation and sequencing were successful for 67
out of 68 samples (quality of sample preparation of DNA
from a fecal sample from a pig in the tetracycline-treated
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group obtained nine days post ended treatment did not
pass quality control). The number of reads, OTU and
Shannon index per sample is stated in Additional file 1:
Table S1. The average Shannon index was significantly
lower in ileum samples (average 1.78 for all ileum samples
combined) then the fecal samples (4.62). There were no
significant differences in the Shannon indexes between
ileal samples from different treatment groups or different
sampling times.
The impact of treatment and time post treatment on the
ileum microbiota composition
Ileum samples were obtained from two, five and five pigs at
time points T[0], T[7] and T[15], respectively. Before treat-
ment start, the samples had a large diversity in microbiota
composition (Fig. 3). At time T[7] a treatment-associated
clustering of ileum microbiota samples from tetracycline-
and sertraline/tetracycline treated groups was observed, while
there were no distinct clustering of ileum samples from pigs
in either control or sertraline treated groups (Fig. 3). For
samples obtained at time T[7] the abundance of the Lactoba-
cillaceae had the most distinct differences between groups.
The level of the Lactobacillaceae had a significantly lower
abundance in the tetracycline and sertraline/tetracycline
treated groups compared to the level in the samples from
the un-medicated control pigs. Furthermore, the abundance
of the Lactobacillaceae was significantly lower in the sertra-
line/tetracycline treated group compared to samples from
the tetracycline- or sertraline-treated groups. In contrast, the
abundance of the Streptococcaceae in the control group was
significantly higher than the abundance of Streptococcaceae
in the tetracycline and sertraline/tetracycline treated groups.
Furthermore, the abundances of Streptococcaceae were sig-
nificantly lower in the sertraline/tetracycline compared to
Fig. 1 Total fecal (_F) and intestinal (_I) tetracycline resistant CFU Numbers (in log10 CFU per gram feces (_F) or ileum (_I)) of total tetracycline
resistant CFU at different time points in four different treatment groups. Vertical bars indicate standard deviations. Timepoint T(− 2) refers to two
days before treatment start, and just prior to oral inoculation of all pigs with a tetracycline/rifampicin resistant Escherichia coli strain. At T(− 2) 12
individual fecal samples were obtained from each group. No pigs were euthanized at this point, therefore no ileum samples were obtained at
T(− 2). Time point T(0) refers to the first treatment day. Samples were obtained prior to the first treatment at the same day. From each group 12
individual fecal samples were obtained. Hereafter, two pigs were euthanized at ileum samples were obtained from 2X4 pigs. Time T(7) refers to
48 h after the last of five days of treatment. From each group 10 individual fecal samples were obtained. Hereafter, five pigs were euthanized and
ileum samples were obtained from 5X4 pigs. Time T(9) refers to nine days after the last of five days of treatment. From each group five individual
fecal samples were obtained. Hereafter, the five pigs in each group were euthanized and ileum samples were obtained from 5X4 pigs. For visual
purposes all CFU counts at the different time points has been included in the same figure, statistical analysis were, however, done for each time
point, each treatment group at different sampling time and sampling site (fecal or ileum) individually. Asterisks over straight lines indicate a
statistical difference at the same time point between treatment groups. Arrows indicate statistical difference at the different time points within
each treatment groups. Hash tag indicates that group is statistically different from the other groups at the same sampling time. Statistical
significant differences between fecal and ileum samples are not shown on the figure
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samples from the tetracycline and sertraline treated groups
(Fig. 4, Additional file 2: Figure S2). The average abun-
dance of Enterobacteriaceae in ileal samples from the
tetracycline-treated group had a significantly higher aver-
age abundance of Enterobacteriaceae compared to any of
three other groups (Fig. 4). For the remaining seven out of
the ten overall most abundant families in the ileum sam-
ples (Fig. 4), there were no significant differences in the
abundances between groups. At time point T[15], there
were no longer any significant differences in the abun-
dances of the 10 most abundant families across all ileal
samples between the different treatment groups (Fig. 4),
and no treatment-associated clustering of the ileum de-
rived microbiota-samples (Additional file 3: Figure S1).
Average daily weight gain between groups
The average daily weight gain per pig per group varied
between 0.4–0.8 g/day. There was no statistical differ-
ence between the groups in average daily weight gain
per group.
Discussion
The main purpose of the study was to investigate if sertra-
line would re-sensitize an intestinal tetracycline-resistant
population of bacteria, in particularly coliforms, to tetra-
cycline in piglets. Secondly, the question as to how oral
treatment with sertraline with or without tetracycline may
impact the gut microbiota composition in relation to
treatment and nine days after withdraw of medication,
was studied.
Initially, there are some methodic issues of the study to
address; First, as regulation of the European Union does
not allow tetracyclines, or any other antibiotics, as in-feed
growth promoters [14], the use of tetracycline in agricul-
ture within EU is always related to a treatment-related
aspect. In pig production tetracycline is the most com-
monly used antibiotic for treatment of enteric diseases [1].
Therefore, it could be argued if an experimental diarrhea
model in pigs would have been more appropriate to ad-
dress the question of helper-drug activity of sertraline.
Such model is, however, fairly difficult to establish
Fig. 2 Indicator E. coli CFU Numbers (in log10 numbers of CFU per gram feces (_F) or ileum (_I)) of an indicator E. coli strain at three different
time points in four different treatment groups. Vertical bars indicate standard deviations. Before the pigs were inoculated with the indicator strain,
no pigs carried a detectable level of the indicator strain in feces (data not shown on the figure). Time point T(0) refers to the first treatment day.
Fecal and ileum samples were obtained prior to the first treatment at the same day. From each group 12 individual fecal samples were obtained.
Hereafter, two pigs were euthanized and ileum samples were obtained from 2X4 pigs. Time T(7) refers to 48 h after the last of five days of
treatment. From each group 10 individual fecal samples were obtained. Hereafter, five pigs were euthanized at ileum samples were obtained
from 5X4 pigs. Time T(15) refers to nine days after the last of five days of treatment. From each group five individual fecal samples were
obtained. Hereafter, the five pigs in each group were euthanized and ileum samples were obtained from 5X4 pigs. For visual purposes all CFU
count at the different time points has been included in the same figure, statistical analysis were, however, done for each time point and
sampling site individually. The asterisk indicate that the ileum samples from the tetracycline treated group had a significant higher level than
ileum samples from the three other groups at time point T(7)
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experimentally with success [15]. Often, only a limited
amount of the pigs would develop diarrhea, likely because
porcine enteritis is a complex disease with several factors
contributing to diarrhea development [16]. Secondly, since
all pigs were initially colonized with tetracycline resistant
bacteria before inoculation with the indicator E. coli bac-
teria, this step could perhaps have been omitted. However,
to ensure that each pig would have an equal challenge of a
marked tetracycline-resistant bacteria, in which sertraline
and tetracycline synergy had been confirmed in vitro [10],
the inoculation step remained in the experimental design.
Thirdly, the concentration of sertraline used to obtain in
vitro synergy with tetracycline, is considerable higher than
the maximal (human) plasma concentrations of sertraline
(0.25mg/L) [17], and therefore negative in vivo results
may have been expected. However, to the authors’ know-
ledge there is no literature available on the concentration
of sertraline in intestine of either animals or humans after
oral medication. In the present study, we used daily doses
of sertraline that would correspond to the maximum dose
given to a person with severe mental disorders e.g. severe
anxiety. Higher doses of sertraline may cause a general im-
mune suppression, which increase the risk of infections
[18]. Finally, even though tetracycline are used less fre-
quently in human medicine than in agriculture, the high
carriage of commensal tetracycline resistant bacteria in
food-producing animals do possess a public risk, in par-
ticular because tetracycline resistance is likely to co-select
for other, more human relevant antibiotics [19], therefore
we find it relevant to investigate synergy of sertraline/
tetracycline on the tetracycline-resistant commensal
microbiota in pigs. Based on these considerations, we find
the experimental design and treatment doses used ap-
propriate to address the research questions raised
above.
The heavily fecal shedding of tetracycline resistant
bacteria in all pigs before the experimental inoculation
(Fig. 1) is most likely caused by the intensive use of anti-
biotics in the pig industry in the last decades, as at a
population level there is a strong association between
the use of antibiotics and the proportion of bacteria re-
sistant to antibiotics [5, 20, 21].
For all treatment groups, the treatments were tolerated
well by the pigs with no clinical signs despite that a
high-dose sertraline were administered to two of the
treatment groups (Group 2 and 4). Toleration of the
clinical relevant concentrations of the helper-drugs by
the animals (or humans) is probably underrated [13] e.g.
in another recent published study evaluating in vivo
helper-compound activity of thioridazine, also a neuro-
trophic active medical compound, the authors report
that their study had to pre-terminate due to severe
side-effects of thioridazine in pigs with the concentra-
tions used [22].
As expected, the pigs did not show clinical affection of
the high-dose inoculum indictor bacteria. Fecal shedding
of the indicator bacteria was very high two days after in-
oculation (Fig. 2), and a part of the inoculum there has
probably mainly transited the intestinal tract with a only
minor degree of colonization in ileum at T[0] (Fig. 2).
For the tetracycline and sertraline/treated groups the
fecal shedding of the indicator bacteria decreased signifi-
cantly from time T[7] to T[15], while level in ileum
remained at the same level as the level at T[0] for all
Fig. 3 Principle component analysis (PCA) of ileum microbiota composition at time T[0] and T[7] Identification of samples with similar microbiota
composition using multivariate statistics (PCA). Each red or blue point represent the microbial community in a specific sample obtained just prior
to treatment start (D0/T[0]) or 48 h after last day of treatment (D1/T[7]), respectively
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groups (Fig. 2) indicating that some degree of intestinal
colonization had occurred. For the tetracycline treated
group, but not the sertraline/tetracycline, there was a
significant increase in the intestinal level of the tetracyc-
line resistant indicator E. coli strain shortly after with-
drawal of tetracycline treatment (Fig. 2). This could
indicate that sertraline may counteract the selective pres-
sure of tetracycline, however, the level of the indicator E.
coli remained as high as the average level of the indicator
bacteria in ileal samples from the un-medicated control
(3.8 log10 CFU) (Fig. 2). Furthermore, within the group of
sertraline/tetracycline treated pigs, there was a rise in the
number of total tetracycline resistant coliform bacteria at
T[7] compared to control group (Fig. 1), hence, the sug-
gested counteracting of a selective pressure, indicated by
the lower level of resistant bacteria in the sertraline/tetra-
cycline compared to tetracycline group, is not likely to
have clinical impact. The difference between the impact of
sertraline/tetracycline on the level of the indicator E. coli
bacteria and the lack of impact on total tetracycline resist-
ant coliforms could possibly be explained by the various
types of tetracycline resistance [23], of which tetracycline
and sertraline synergy has only been documented for the
efflux-mediated type of tetracycline resistance, a mode of
action present in the indicator E. coli strain [10].
The results on the selective pressure on the indicator
bacteria is in contrast with the observations on the total
tetracycline resistant coliforms at T[7], in the fecal sam-
ples. The fecal samples from tetracycline and sertraline/
tetracycline treated groups had similar levels of tetracyc-
line resistant coliforms, and the level tetracycline resist-
ant coliforms of these two groups was significantly
higher than the control group level at T[7] (Fig. 1). Simi-
larily, theof intestinal tetracycline resistant coliforms was
also significantly higher in the tetracycline treated group
compared to the control group (Fig. 1). The finding of
tetracycline treatment may select for a higher level of re-
sistant bacteria followed by a return to the level before
Fig. 4 The 10 most abundant families in ileum samples obtained at time T[0], T[7] and T[15] The 10 most abundant genera in percent. Each has
both a broad name (Phylum) and a specific name (Family). Samples were obtained from each treatment just prior to treatment start (D0/T[0]), 48
h after last day of treatment (D1/T[7]) and nine days after last day of treatment (D9/T[15])
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medication in a time span (in our study, nine days) from
last day of short-time antibiotic treatment (Fig. 1)) is in
accordance with previous observations [24]. However,
nine days after ended treatment both the tetracycline
and sertraline/tetracycline treated groups had levels of
fecal tetracycline resistant coliform comparable to the
un-medicated control group, implying that sertraline do
not potentiate the effect of tetracycline in a population
with a high proportion of commensal, tetracycline resist-
ant bacteria. For the intestinal samples, however, the
tetracycline treated group was the only group in which
the level of tetracycline resistant coliforms remained sig-
nificantly higher nine days after treatment compare to
the level before treatment for the same group (Fig. 1).
The level of tetracycline resistant coliforms were, never-
theless, not higher in the tetracycline group at nine days
after ended treatment compared to the other treatment/
control groups. Taken together, these results of the
present study confirm a recent study by Graesboll et al.
[24] reporting that five days treatment with tetracycline
may transiently result in increased total count and pro-
portion of tetracycline resistant coliform (Fig. 1).
In agreement with the significantly increased level of tetra-
cycline resistant bacteria right after ended treatment for
tetracycline (+/− sertraline) treated groups, treatment-associ-
ated grouping of ileal microbiota samples of pigs from Group
2 (tetracycline treated) and Group 4 (sertraline/tetracycline
treated) were found (Fig. 3). Samples from Group 2 and 4 as-
sembled individually, while samples from un-mediated con-
trol pigs and sertraline treated pigs did not demonstrate
treatment-associated microbiota uniformities. The different
compositions of microbiotas indicate that sertraline com-
bined with tetracycline has an interactive effect that is differ-
ent from the impact of the sum of changes caused by
individual treatment with either sertraline or tetracycline,
proposing that there might be some synergy or at least inter-
action between tetracycline and sertraline on the microbiota
composition in vivo.
Nine days after ended treatment there were no indica-
tion of treatment-associated clustering of ileum-derived
microbiotas (Additional file 3: Figure S1), corresponding
to the observations done on comparisons of CFU counts
from the different treatment groups.
The amount on literature concerning the microbiota
of animals as humans has increased almost exponentially
the last decade. Yet, the optimal intestinal microbiota
composition is yet to be described. Nevertheless, a re-
cent publication combining metagenomics and microbial
function genetics and the impact of in-feed antibiotics
has enlighten the understanding on how a shift in bac-
terial population may also shift energy production and
conversion and, hence, growth of the pigs. In the above
mentioned study, feeding pigs with a commercial available
(in the US) performance-enhancing mix of antibiotics lead
to a bacterial shift, dominated by an increase in phylum
Proteobacteria, in particular E. coli, in the medicated pig
compared to the un-medicated control [25]. These obser-
vations are in agreement with the present study, in which
a significant increase in the abundance of E. coli in ileal
samples from the tetracycline-treated pigs compared with
ileum samples from the un-treated control pig (Additional
file :3 Figure S1). The unique increase in the abundance of
E. coli in the tetracycline treated group at time point T[7]
is in agreement with the unique increase of the CFU per
gram of indicator E. coli at the same time point. The same
increases in either abundance or CFU count of E. coli
were, however, not evident in the ileum samples from the
pigs treated with tetracycline in combination with sertra-
line (Fig. 1 Fig. 4). Rather, for the latter mentioned group
the level of the family Streptococcaece was significantly
increased, while the abundances of the family of Lactoba-
cillaceae was dramatically decreased at time point T[7].
Lactobacillus spp. are probably the most treasured bacteria
in term of general health-promoting probiotic effects [26],
and hence a low level of lactobacillus would be considered
strongly un-favorable. It can be concluded that sertraline
and tetracycline have an interaction that create a measur-
able response on CFU per gram and microbiota compos-
ition right after ended treatment, although the effect may
neither be major (in terms of decreasing the level of tetra-
cycline resistant coliforms) nor beneficial (in terms of an
optimal microbiota composition). However, in accordance
with the observations done on the cultivable bacteria, the
microbiota compositions nine days after withdrawal of
treatment did no longer show any association with any pre-
vious treatments (Fig. 4, Additional file 2: Figure S1), under-
ling that the five days of treatment with tetracycline in
therapeutic concentrations (+/− sertraline) did not have
long-lasting effects on the intestinal bacterial population, in-
cluding the tetracycline resistant population.
Conclusion
The high carriage of antimicrobial resistance bacteria in
the porcine autochthonous microbiota calls for new treat-
ment strategies to ensure continuous treatment success
and human food safety. In this study, the impact of sertra-
line as a tetracycline helper-compound had only very lim-
ited effect and is not likely to have a clinical importance.
Furthermore, the increased level of tetracycline-resistant
coliforms in the tetracycline-medicated group (without
sertraline added) shortly after ended treatment returned
to a level comparable to the un-medicated control group
in less than two weeks after ended treatment. Similarly,
the composition of ileal microbiota from tetracycline and
tetracycline/sertraline medicated groups, clustered accord-
ing to treatment only immediately after treatment. Nine
days after ended treatment no treatment-associated effect
could be detected.
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In conclusion under the conditions tested there were
no beneficial effect of sertraline as a tetracycline helper-
compound, despite the previously reported promising in
vitro synergy between tetracycline and sertraline.
Nevertheless, the carriage of high level of tetracycline-
resistant bacteria among all of the commercial bought
piglets used in the study, calls for more prudent anti-
biotic use in the pig production, new antibiotics or novel
efficient helper-compound to re-sensitize bacteria to the
traditional antibiotics.
Methods
Pigs and housing
Forty-eight healthy female Danish landrace piglets (seven
weeks of age) with normal faecal consistency were bought
from a commercial pig producer. Unfortunately, data on
previous antibiotic treatment for each individual pig was
not available. At arrival at the experimental animal unit of
University of Copenhagen, Frederiksberg campus the pigs
were weighted and randomly allocated to one of four
groups, placed in four different pens. Hereafter, the pigs
were allowed to acclimatize for one week before starting
the trial. The pigs were kept on restricted diet of commer-
cial feed (Svine Erantis Brogaarden ApS, Lynge, Denmark)
according to age (550 g/pig/day) and had free access to
tap water. The pigs were euthanized by an initially anes-
thetizing shoot with a captive bolt-pistol followed by inci-
sion on jugular vein and bleeding of the pigs. All
procedures performed on the pigs were approved and li-
censed by the Danish Animal Experiments Inspectorate
(license no. 2016-15-0201-01144).
Experimental design
After one week of acclimatization and two days before
treatment start (time point T[− 2]), all pigs were
weighted and fecal samples were obtained from all 12
pigs in each of the four groups. Hereafter all pigs were
orally inoculated with a tetracycline-resistant indicator
strain of E. coli (strain details are given below) in 50mL
of water-diluted, blended, soft cat food (supermarket
brand), which the pig found highly palatable. Inoculation
was thus voluntary and stress-free for all pigs, which en-
sured that all pigs be equally and heavily colonized with
a rifampicin-marked tetracycline resistant strain of E.
coli. Two days after inoculation and just prior to treat-
ment start (time point T[0]), all pigs were weighted and
individual fecal samples were obtained. Two randomly
chosen pigs from each group were hereafter euthanized,
and ileum samples were obtained from these eight pigs
to represent the ileal microbiota composition before
treatment. At the same day, the pigs in Group 2 (tetracycline
treated), Group 3 (sertraline treated) and Group 4 (sertra-
line/ tetracycline treated) received individual, voluntary oral
treatment (sertraline or compounds dissolved in blended cat
food) for five consecutive days (Doxylin© (Dopharma Re-
search, Raamsdonksveer, Netherlands) (24mg/kg body
weight corresponding to 12.5mg doxycycline (a tetracycline
antibiotic)/kg body weight; Sertrone© (KRKA Sverige,
Stockholm, Sweden) (one 100mg sertraline-containing tab-
let daily, corresponding to approximately four mg/kg body
weight). Pigs in Group 1 remained un-medicated, but re-
ceived the same amount (10ml) of the water-diluted
blended cat food. During the treatment period, pigs in
Group 2 and 4 were weighted each day to adjust the amount
of Doxylin per pig per kg body weight per day. Forty-eight
hours after ended treatment period (time point T[7]), fecal
samples were obtained from all pigs and hereafter five pigs
in each group were chosen randomly and euthanized
followed by obtaining of ileum samples from all euthanized
pigs. The remaining five pigs in each group remained
un-medicated the following nine days post treatment. Nine
days after ended treatment (time point T[15]), individual
fecal samples were obtained, pigs were euthanized and ileum
samples were collected from all pigs as well. All pigs were
clinically healthy throughout the study period.
Fecal samples were obtained by either spontaneously
defecation without the sample reaching the floor or ob-
tained directly from rectum. All samples were collected
with sterile latex gloves.
Ileum samples were obtained by localising the ostium
ileocecale and hereafter measuring five cm in the oral dir-
ection. At this location a sterile pean was placed to oc-
clude the intestinal lumen. Another 10 cm in the oral
direction were measured and a second occlusive pean
placed to allow resection of the ileal segment. The section
was placed on a disinfected table and cut open to expose
the mucosal surface. A sterile glass microscope slide was
used to scrape five times into the depth of the mucosal
layer. All material hereof, i.e. the mucosal tissue and intes-
tinal content, was transferred to a sterile petri dish.
All samples were processed (serial dilution plating or
DNA extraction) within the same day the samples had
been collected.
Preparation of inoculum of indicator bacteria
The E. coli tetracycline resistant “E. coli O2” was chosen
as an indicator strain because in vitro synergy with ser-
traline has been documented and investigated in detail
[10]. Secondly, the strain does not contain any of the
primary virulence factors associated with porcine entero-
toxigenic E. coli (toxins, fimbria F4/F18 ect.) [27]. The
strain contains two large plasmids; one encoding resis-
tances toward seven different antimicrobials, including
tetracycline [28], and a virulence plasmid [29], genes en-
coding for increased survival in extra-intestinal compart-
ments, e.g. the human urinary tract system [30]. For
re-isolation purposes, rifampicin resistance was induced
by standard procedures. The rifampicin mutant strain
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was confirmed to have the same tetracycline resistance
properties and synergy with tetracycline as previously re-
ported for the wild-type strain of E. coli O2 [10].
The strain had been stored at − 80 °C in Brain and
Heart Infusion (BHI) broth (Oxoid, Basingstoke, UK) in
15% (v/v) glycerol until needed. The day before inocula-
tion four colonies of the strain were picked from an agar
plate (Oxoid, CM0055) supplemented with 5% calf
blood. Each colony was inoculated into a flask contain-
ing 250 mL BHI broth and incubated at 37 °C without
shaking for 24 h to reach a concentration of approximately
109 CFU. The four overnight grown cultures were pooled
to one culture in a sterile Blue cap bottle (Sigma-Aldrich,
Copenhagen, Denmark) and distributed into 50mL centri-
fuge tubes each containing 40mL of the pooled culture
and centrifuged at 4 °C at 3000G for 15min. Subsequently,
the supernatant in each tube was discharged and the pellet
re-suspended in 10ml phosphate buffered solution (PBS),
and again pooled together in one pool, of which each pig
orally received five ml. To determine the exact dose ad-
ministered to each pig, 100 μl of the pooled, re-suspended
bacterial solution was used to make a 10-fold serially dilu-
tions until 10− 11 dilution and from each dilution, 100 μl
was plated on MH ager (Oxoid Ltd., Thermo Scientific,
Roskilde, Denmark) to determine the final inoculation
dose of 2 × 1012 CFU per pig.
Bacterial quantification
Approximately one gram of each sample (fecal or ileum
was diluted 1:10 in PBS in a Biomaster 80© filter bag
(Stomacher, Seward Inc., Port Saint Lucie, FL, USA) and
homogenized in a Stomacher machine (Stomacher, Sew-
ard Inc) for 1min. Subsequently, serial 10-fold dilutions
were made in 0.9% NaCl solution. From all dilutions
(10−1to 10− 7), 10 μl were spotted on agar plates containing
the following two media: MacConkey agar supplemented
with 8mg/L tetracycline (for enumeration of total tetra-
cycline resistant coliforms), and MacConkey agar supple-
mented with 8mg/L tetracycline, 50mg/L ampicillin
(Sigma-Aldrich) and 25mg/liter rifampicin (Sigma-Al-
drich) (For enumeration of the indicator strain E. coli).
E. coli K-12 MG1655 (tetracycline sensitive) and E. coli
NCTC 50078 (tetracycline resistant) were included as
control strains on all plates. For MacConkey agar supple-
mented with tetracycline, rifampicin and ampicillin, the
inoculum strain (E. coli_O2 [31]) was included as well.
All serial dilutions were done and plated in duplicates.
The plates were aerobically incubated for 24 h at 37 °C
followed by colony enumeration.
For each plate, a count, expressed as the number of
CFU per gram, was determined using a weighed arith-
metic mean based on the two highest dilutions showing
the separation between colonies, and finally, the number
of CFU per gram was log10 transformed. To avoid
exclusion of samples with a CFU per gram equaling zero
from the analysis (as 0 cannot be log10 transformed), all
numbers of CFU per gram sample, was added a constant of
1. This constant was chosen because log10 to 1 equals 0.
PCR confirmation of re-isolation of inoculated indicator
strain E. coli_O2
To verify that the isolates from fecal or ileal samples
growing on the agar plate containing MacConkey sup-
plemented with tetracycline, rifampicin and ampicillin
plate were identical to the inoculum strain of E. coli, two
randomly chosen isolates from each pig were confirmed
as identical to the inoculum strain by an E. coli_O2 spe-
cific PCR as described in Kromann et al. (2017) [32].
DNA extraction of fecal and ileum samples
Total DNA from 48 ileal and10 fecal samples, respect-
ively, were extracted for determination of the microbiota
composition. From the 10− 1 diluted homogenates used
for the enumeration of bacteria, 800 μl homogenate from
each of the samples was transferred to a 2 mL FastPrep©
Lysis matrix E tube (MP Biomedical, Solon, OH, USA)
and further homogenized on a FastPrep-24 Instrument
(MP Biomedical) at 6 m/sec for 40 s, followed by centri-
fugation for 15 min at 10000G. Subsequently, 400 μl of
the supernatant of each sample were processed on a
Maxwell© RSC instrument (Promega Corporation,
Mannheim, Germany) applying the RSC PureFood
GMO kit (Cat. # AS1600) according to manufacturer’s
protocol for extraction of DNA.
DNA concentrations were measured on an Agilent
2100 Bioanalyzer (Agilent Technologies, Waldbronn,
Germany) before 16S rRNA gene amplicon library
preparation.
16S rRNA gene amplicon library preparation
Bacterial V3–4 16S rRNA gene sequencing libraries of
extracted DNA from 48 ileal samples and 10 fecal sam-
ples were prepared by a custom protocol based on an
Illumina (Illumina, San Diego, CA, USA) protocol [33]
according to previously done by Olsen et al. 2017 [34].
Briefly, for PCR amplification of the 16S rRNA gene
fragments, 10 ng of extracted DNA was used as tem-
plate. Each PCR reaction (25 μL) contained dNTPs
(100 μM of each), MgSO4 (1.5 mM), Platinum® Taq
DNA polymerase HF (2 mU), 1X Platinum® High Fidelity
buffer (Thermo Fisher Scientific, USA) and tailed primer
mix (400 nM of each forward and reverse). PCR condi-
tions included: An nitial denaturation at 95 °C for 2 min,
35 cycles of amplification (95 °C for 20 s, 50 °C for 30 s,
72 °C for 60 s) and a final elongation at 72 °C for 5 min.
Duplicate PCR reactions was performed for each sample
and the duplicates were pooled after PCR. The forward
and reverse tailed primers were designed according to
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Vo and Jedlicka [33] and contain a primer parts target-
ing the respective 16S rRNA gene fragments. Bacteria
V3–4 [35]: 5’-CCTACGGGNGGCWGCAG (341F) and
5’-GACTACHVGGGTATCTAATCC (805R). The primer
tails enable attachment of Illumina Nextera adaptors for
sequencing in a subsequent PCR. The amplicon libraries
were purified using Agencourt Ampure XP Bead (Beck-
man Coulter) using vendor recommended protocol,
using a bead to sample ratio of 4:5 and the DNA was
eluted in 33 μL of nuclease free water (Qiagen, Hilden,
Germany). DNA concentration was measured using
Quant-iT DNA Assay Kit, high sensitivity (Thermo
Fisher Scientific, Roskilde, Denmark). Sequencing librar-
ies were prepared from the purified amplicon libraries
using a second PCR. Each PCR reaction (25 μL) con-
tained 1x PCRBIO HiFi buffer (PCR Biosystems Ldt,
London, UK), PCRBIO HiFi Polymerase (1 U) (PCR Bio-
systems Ldt), adaptor mix (400 nM of each forward and
reverse) and 2 μL of amplicon library template. PCR was
run with the following program: Initial denaturation at
95 °C for 2 min, 8 cycles of amplification (95 °C for 20 s,
55 °C for 30 s, 72 °C for 60 s) and a final elongation at
72 °C for 5 min. The sequencing libraries were purified
using Agencourt Ampure XP Bead (Beckman Coulter,
Redlands, CA, USA) using vendor recommended proto-
col, using a sample/bead ratio of 5:4 and the DNA was
eluted in 20 μL of nuclease free water (Qiagen). DNA
concentration was measured using Quant-iT DNA Assay
Kit, high sensitivity (Thermo Fisher Scientific). Gel elec-
trophoresis using Tapestation 2200 and D1000 High
Sensitivity screentapes (Agilent Technologies) was used
to check the product size and purity of randomly picked
sequencing libraries.
DNA sequencing
The purified sequencing libraries were pooled in equi-
molar concentrations and diluted to 4 nM. The samples
were paired end sequenced (2x301bp) on a MiSeq (Illu-
mina) using a MiSeq Reagent kit v3, 600 cycles (Illu-
mina) following the standard guidelines for preparing
and loading samples on the MiSeq. 20% Phix control li-
brary was spiked in to overcome low complexity issue
often observed with amplicon samples.
16S rRNA gene amplicon bioinformatic processing
Forward and reverse reads were trimmed for quality
using the software Trimmomatic v. 0.32 [36] with the
settings SLIDINGWINDOW:5:3 and MINLEN:275. The
trimmed forward and reverse reads were merged using
the program FLASH v. 1.2.7 [37], with the settings -m
25 -M 200. The merged reads were dereplicated and for-
matted for use in the UPARSE workflow [38]. The dere-
plicated reads were clustered, using the usearch v.
7.0.1090 -cluster_otus command with default settings.
Operational Taxanomic Units (OUT) abundances were
estimated using the usearch v. 7.0.1090 -usearch_global
command with -id 0.97. Taxonomy was assigned using
the RDP classifier [39] as implemented in the paralle-
l_assign_taxonomy_rdp.py script in QIIME [40], using
the MiDAS database v.1.23 [41]. The results were ana-
lysed in R [42] through the Rstudio IDE using the amp-
vis package v.2.0 [43].
Average weight gain
The average weight gain per pig was calculated as differ-
ence in body weight from the day of arrival to the ex-
perimental unit compared to the body weight of the pig
at the day of euthanization divided by the days spend at
the experimental unit.
Statistical analysis
Statistical analyses were done using the software Graphpad
Prism version 7 (Graphpad Software, Inc., La Jolla, CA,
USA). At each time sampling point, differences between
groups for log10 CFU on the five different types of agar
plates, proportions of CFU counts, and abundances of differ-
ent genera in the microbiota or average weight gain/group
were analysed by one-way ANOVA. In addition, differences
within each group at different sampling times were analysed
in the same manner. The one-way ANOVA was followed by
Turkey’s t-test for multiple comparisons. A statistical differ-
ence of P < 0.5 was considered statistically significant.
Additional files
Additional file 1: Table S1. Sample concentration and number of reads
after sequencing. “Reads” is the number of reads after sequencing after
sequencing, quality control and bioinformatics processing, “Observed” is
the number of observed operational taxonomic units in 10000 reads,
while Shannon is the Shannon index observed in 10000 reads. (DOCX 19
kb)
Additional file 2: Figure S2. The 25 most abundant families genera. The
overall 25 most abundant genera in percent. Each has both a broad name
(Phylum) and a specific name (Genus). Samples from the untreated control
group ©, sertraline treated (S), tetracycline (T) and sertraline/tetracycline
treated groups were obtained (ST) (D0/T[0]), 48 h after last day of treatment
(D1/T[7]) and nine days after last day of treatment (D9/T[15]). Feces samples
were only obtained nine days after ended treatment just prior to treatment
start. From the latter two, samples P01, P06, P07, P08 and P09 were
obtained from pigs in the un-medicated control group, while samples P14,
P17, P19, P20 and P22 were obtained from pigs that had received tetracyc-
line treatment. (JPG 149 kb)
Additional file 3: Figure S1. Principle component analysis (PCA) of
ileum microbiota composition at time T[0] and T[15]. Identification of
samples with similar microbial communities using multivariate statistics
(PCA). Each red or blue point represent the microbita composition in a
specific sample obtained just prior to treatment start (D0/T[0]) or nine
days after the last day of treatment (D9/T[15]), respectively. (JPG 42 kb)
Abbreviations
CFU: Colony forming units; OUT: Operational Taxanomic Units;
PCR: Polymerase Chain Reaction; SSRI: Selective Serotonin Reuptake Inhibitor
Kromann et al. BMC Microbiology           (2019) 19:12 Page 10 of 12
Acknowledgments
Technician Dan Ryttov is thanked for skillful laboratory assistance. DNAsense
is thanked for the high-quality sequencing of 16S rDNA.
Funding
This project has received funding from the Danish Council of Independent
Research (DCIR) grant agreement no. 4184–00512. The DCRI did not
participate in designing the study, the analysis of and interpretation of data,
nor in writing the manuscript.
Availability of data and materials
All data are available by request to the corresponding author.
Authors’ contributions
All authors contributed to the design of the experiment. SK, RHO, DBS and
AH conducted the experimental treatment of pigs, sampling, bacterial
cultivation and DNA extractions. RHO prepared samples for metagenomic
sequencing. RHO, MB,SJ and JPN prepared the manuscript. All authors
contributed to critical revision of the manuscript. All authors read and
approved the final manuscript.
Ethics approval and consent to participate
All procedures performed on the pigs were approved and licensed by the
Danish Animal Experiments Inspectorate (license no. 2016-15-0201-01144).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 15 October 2017 Accepted: 27 December 2018
References
1. The Danish Integrated Antimicrobial Resistance Monitoring and Research
Programme (DANMAP). 2012.
2. Sengelov G, Halling-Sorensen B, Aarestrup FM. Susceptibility of Escherichia
coli and enterococcus faecium isolated from pigs and broiler chickens to
tetracycline degradation products and distribution of tetracycline resistance
determinants in E. coli from food animals. Vet Microbiol. 2003;95:91–101.
3. Zhang Y, Boyd SA, Teppen BJ, Tiedje JM, Li H. Role of tetracycline speciation
in the bioavailability to Escherichia coli for uptake and expression of
antibiotic resistance. Environ Sci Technol. 2014;48:4893–900.
4. Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cell
Mol Life Sci. 2010;67:419–31.
5. Burow E, Simoneit C, Tenhagen BA, Kasbohrer A. Oral antimicrobials
increase antimicrobial resistance in porcine E. coli--a systematic review. Prev
Vet Med. 2014;113:364–75.
6. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP,
Teillant A, Laxminarayan R. Global trends in antimicrobial use in food
animals. Proc Natl Acad Sci U S A. 2015;112:5649-54.
7. Martins M, Dastidar SG, Fanning S, Kristiansen JE, Molnar J, Pages JM, Schelz
Z, Spengler G, Viveiros M, Amaral L. Potential role of non-antibiotics (helper
compounds) in the treatment of multidrug-resistant gram-negative
infections: mechanisms for their direct and indirect activities. Int J
Antimicrob Agents. 2008;31:198–208.
8. Nikaido H. Prevention of drug access to bacterial targets: permeability
barriers and active efflux. Science. 1994;264:382–8.
9. Ayaz M, Subhan F, Ahmed J, Khan AU, Ullah F, Ullah I, Ali G, Syed NI,
Hussain S. Sertraline enhances the activity of antimicrobial agents against
pathogens of clinical relevance. J Biol Res (Thessalon ). 2015;22:4.
10. Li L, Kromann S, Olsen JE, Svenningsen SW, Olsen RH. Insight into
synergetic mechanisms of tetracycline and the selective serotonin reuptake
inhibitor, sertraline, in a tetracycline-resistant strain of Escherichia coli. J
Antibiot (Tokyo). 2017;70:944–53.
11. Munoz-Bellido JL, Munoz-Criado S, Garcia-Rodriguez JA. In-vitro activity of
psychiatric drugs against Corynebacterium urealyticum (Corynebacterium
group D2). J Antimicrob Chemother. 1996;37:1005–9.
12. Amlesh S, Chattopadhyayb D, Sinha C, Janaa A, Ghosha S, Banerjeea A,
Hendricks O, Christensen J, Kristiansen J. Evaluation of In Vivo and In Vitro
antimicrobial activities of a selective serotonin reuptake inhibitor sertraline
hydrochloride. Anti-Infective Agents. 2012;10:95–104.
13. Bohnert JA, Szymaniak-Vits M, Schuster S, Kern WV. Efflux inhibition by
selective serotonin reuptake inhibitors in Escherichia coli. J Antimicrob
Chemother. 2011;66:2057–60.
14. Anonym. Regulation 1831/2003/EC on additives for use in animal nutrition.
In: Replacing directive 70/524/EEC on additives in feeding-stuffs; 2003.
15. Madec F, Bridoux N, Bounaix S, Cariolet R, Duval-Iflah Y, Hampson DJ, Jestin
A. Experimental models of porcine post-weaning colibacillosis and their
relationship to post-weaning diarrhoea and digestive disorders as
encountered in the field. Vet Microbiol. 2000;72:295–310.
16. Weber N, Nielsen JP, Jakobsen AS, Pedersen LL, Hansen CF, Pedersen KS.
Occurrence of diarrhoea and intestinal pathogens in non-medicated nursery
pigs. Acta Vet Scand. 2015;57:64.
17. Boumba VA, Rallis G, Petrikis P, Vougiouklakis T, Mavreas V. Determination of
clozapine, and five antidepressants in human plasma, serum and whole
blood by gas chromatography-mass spectrometry: a simple tool for clinical
and postmortem toxicological analysis. J Chromatogr B Analyt Technol
Biomed Life Sci. 2016;1038:43–8.
18. Gobin V, Van SK, Denys D, Deforce D. Selective serotonin reuptake inhibitors
as a novel class of immunosuppressants. Int Immunopharmacol. 2014;20:
148–56.
19. Kanwar N, Scott HM, Norby B, Loneragan GH, Vinasco J, Cottell JL, Chalmers
G, Chengappa MM, Bai J, Boerlin P. Impact of treatment strategies on
cephalosporin and tetracycline resistance gene quantities in the bovine
fecal metagenome. Sci Rep. 2014;4:5100.
20. Simoneit C, Burow E, Tenhagen BA, Kasbohrer A. Oral administration of
antimicrobials increase antimicrobial resistance in E. coli from chicken-a
systematic review. Prev Vet Med. 2015;118:1–7.
21. Vieira AR, Houe H, Wegener HC, Lo Fo Wong DM, Emborg HD.
Association between tetracycline consumption and tetracycline
resistance in Escherichia coli from healthy Danish slaughter pigs.
Foodborne Pathog Dis. 2009;6:99–109.
22. Stenger M, Behr-Rasmussen C, Klein K, Gronnemose RB, Andersen TE,
Klitgaard JK, Kolmos HJ, Lindholt JS. Systemic thioridazine in combination
with dicloxacillin against early aortic graft infections caused by
Staphylococcus aureus in a porcine model: in vivo results do not reproduce
the in vitro synergistic activity. PLoS One. 2017;12:e0173362.
23. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications,
molecular biology, and epidemiology of bacterial resistance. Microbiol Mol
Biol Rev. 2001;65:232–60.
24. Graesboll K, Damborg P, Mellerup A, Herrero-Fresno A, Larsen I, Holm A,
Nielsen JP, Christiansen LE, Angen O, Ahmed S, Folkesson A, Olsen JE. Effect
of tetracycline dose and treatment mode on selection of resistant coliform
Bacteria in nursery pigs. Appl Environ Microbiol. 2017;83.
25. Looft T, Johnson TA, Allen HK, Bayles DO, Alt DP, Stedtfeld RD, Sul WJ,
Stedtfeld TM, Chai B, Cole JR, Hashsham SA, Tiedje JM, Stanton TB. In-feed
antibiotic effects on the swine intestinal microbiome. Proc Natl Acad Sci U
S A. 2012;109:1691–6.
26. Suda Y, Villena J, Takahashi Y, Hosoya S, Tomosada Y, Tsukida K, Shimazu T,
Aso H, Tohno M, Ishida M, Makino S, Ikegami S, Kitazawa H. Immunobiotic
lactobacillus jensenii as immune-health promoting factor to improve
growth performance and productivity in post-weaning pigs. BMC Immunol.
2014;15:24.
27. Melkebeek V, Goddeeris BM, Cox E. ETEC vaccination in pigs. Vet Immunol
Immunopathol. 2013;152:37–42.
28. Johnson TJ, Siek KE, Johnson SJ, Nolan LK. DNA sequence and comparative
genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible
R plasmid. Antimicrob Agents Chemother. 2005;49:4681–8.
29. Johnson TJ, Siek KE, Johnson SJ, Nolan LK. DNA sequence of a ColV plasmid
and prevalence of selected plasmid-encoded virulence genes among avian
Escherichia coli strains. J Bacteriol. 2006;188:745–58.
30. Skyberg JA, Johnson TJ, Johnson JR, Clabots C, Logue CM, Nolan LK.
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E.
coli isolate enhances its abilities to kill chicken embryos, grow in human
urine, and colonize the murine kidney. Infect Immun. 2006;74:6287–92.
Kromann et al. BMC Microbiology           (2019) 19:12 Page 11 of 12
31. Jorgensen SL, Kudirkiene E, Li L, Christensen JP, Olsen JE, Nolan L, Olsen RH.
Chromosomal features of Escherichia coli serotype O2:K2, an avian
pathogenic E. coli. Stand Genomic Sci. 2017;12:33.
32. Kromann S, Kudirkiene E, Li L, Thofner I, Christensen JP, Olsen RH. Treatment
with high-dose antidepressants severely exacerbate the pathological
outcome of experimental Escherichia coli infections in poultry. PLoS One. In
press.
33. Vo AT, Jedlicka JA. Protocols for metagenomic DNA extraction and Illumina
amplicon library preparation for faecal and swab samples. Mol Ecol Resour.
2014;14:1183–97.
34. Olsen R, Kudirkiene E, Thofner I, Pors S, Karlskov-Mortensen P, Li L,
Papasolomontos S, Angastiniotou C, Christensen J. Impact of egg
disinfection of hatching eggs on the eggshell microbiome and bacterial
load. Poult Sci. 2017;96:3901–11.
35. Herlemann DP, Labrenz M, Jurgens K, Bertilsson S, Waniek JJ, Andersson AF.
Transitions in bacterial communities along the 2000 km salinity gradient of
the Baltic Sea. ISME J. 2011;5:1571–9.
36. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina
sequence data. Bioinform. 2014;30:2114–20.
37. Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to
improve genome assemblies. Bioinform. 2011;27:2957–63.
38. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon
reads. Nat Methods. 2013;10:996–8.
39. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid
assignment of rRNA sequences into the new bacterial taxonomy. Appl
Environ Microbiol. 2007;73:5261–7.
40. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights
D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M,
Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T,
Zaneveld J, Knight R. QIIME allows analysis of high-throughput community
sequencing data. Nat Methods. 2010;7:335–6.
41. McIlroy SJ, Saunders AM, Albertsen M, Nierychlo M, McIlroy B, Hansen AA,
Karst SM, Nielsen JL, Nielsen PH. MiDAS: the field guide to the microbes of
activated sludge. Database (Oxford). 2015;2015:bav062.
42. Core Team R. A language and environment for statistical computing. R
Foundation for statistical computing. Austria: Core Team R; 2015.
43. Albertsen M, Karst SM, Ziegler AS, Kirkegaard RH, Nielsen PH. Back to basics - the
influence of DNA extraction and primer choice on phylogenetic analysis of
activated sludge communities. PLoS One. 2015;10:e0132783.
Kromann et al. BMC Microbiology           (2019) 19:12 Page 12 of 12
